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Background: Multimorbidity is defined as two or more co-existing chronic conditions in an indi-
vidual and is common in general practice. It is associated with poorer outcomes for patients.
This study aimed to establish the prevalence of multimorbidity in patients with chronic respi-
ratory disease in general practice and to describe its impact on health service use.
Methods: Cross-sectional study based in general practice in Dublin. Drug and disease code
searches were performed to identify adult patients with a diagnosis of chronic respiratory
disease. Medical records were reviewed for chronic respiratory diagnosis, other chronic condi-
tions, demographic characteristics, General Practitioner (GP) and practice nurse utilisation
rates, and numbers of medications.
Results: In a general practice population of 16,946 patients 3.9% had chronic respiratory disease
and 60% of these had one ormore co-existing chronic condition(s). GPand practice nurse utilisation
rates, and number of medications were significantly higher among those with multimorbidity
compared with those with respiratory disease alone. Multivariate analysis showed that increasing
age and low socio-economic status were significantly associated with multimorbidity.
Conclusion: Themajority of patientswith chronic respiratory disease havemultimorbidity. Clinical
guidelines based on single disease entities and outcomes are not as easy to implement andmay not
be as effective in this group.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Multimorbidity has been defined as two or more co-existing
chronic conditions within an individual.1e3 It is of particular1 8961087.
O’Kelly).
0 Elsevier Ltd. All rights reservedrelevance for patients, their carers and healthcare
providers as previous studies have shown an inverse rela-
tionship between increasing numbers of co-existing
diseases and health-related quality of life.4e6 Qualitative.
Total Sample
Chronic respiratory disease and multimorbidity 237work has established that the main concerns for patients
with multimorbidity are loss of function, polypharmacy,
a negative effect on their well-being and relationships, and
difficulties with co-ordination of their care.7,8
Previous studies have demonstrated high levels of co-
existing disease among those with chronic respiratory
disease, although most have limited the conditions studied
to a pre-defined list.9e13 The presence of co-existing
conditions in patients with chronic respiratory disease has
been shown to reduce health-related quality of life,14
reduce the potential benefits of rehabilitation,15 and
contribute to mortality.16,17
Managing the health needs of patients with multi-
morbidity is an integral part of routine general practice.
However, there has been relatively little published
research on the subject to date.18 Chronic respiratory
disease is among the most prevalent conditions in the
literature on multimorbidity.1,2
The aim of this study was to establish the prevalence of
multimorbidity in adult patients with chronic respiratory
disease in general practice, categorise the number and
types of additional chronic conditions recorded, and to
describe demographic characteristics, GP and practice
nurse utilisation rates and numbers of medications in adult
patients with chronic respiratory disease with and without
multimorbidity.
Methodology
Study design
Cross-sectional descriptive study based on a review of
medical records by a clinical (GP) research fellow in three
general practice populations.
Setting
The study was based in three general practices in urban
areas in Dublin. The structure of Irish general practice is
outlined in Fig. 1 and further details are available else-
where.19 The practices used in this study were selected
from the Trinity College Dublin network of research and
teaching practices. The proportion of patients qualifying
for free medical care under the General Medical Services
(GMS) scheme was similar in the study practices and
representative of the general population.Primary healthcare services are free through the General Medical Services (GMS) 
scheme to the poorest 30% of the population. Eligibility is means-tested based on the 
total income in a household. At the time of the study primary care services were also 
free for those aged 70 years or older (from January 2001 – December 2008). 
Secondary care is free for all patients.
Registration with a practice is only required if in GMS scheme; there is extensive use 
of computes in practices though few have disease registers; there are no specific 
financial incentives for operating recall systems to monitor quality of care
Free prescriptions only available within GMS scheme; others pay full costs of 
medicines up to monthly limit of €100 per family 
Figure 1 Description of healthcare system in the Republic of
Ireland.Patient identification
Disease code and drug searches were undertaken by the GP
researcher within the computerised database in each
practice. The disease code search identified patients
registered with four codes from the International Classifi-
cation of Primary Care (ICPC),20: chronic bronchitis, chronic
obstructive pulmonary disease, asthma and “respiratory
disease other”. Codes for acute respiratory events and lung
cancer were not included. The research group which
includes three general practitioners and a consultant
respiratory physician devised a list of the most commonly
used respiratory-specific drugs. The drug list consisted of
the following groups: Beta2-agonists, inhaled steroids,
xanthines, sodium cromoglycate, montelukast, anticholin-
ergics, and combination preparations. The database in each
practice was used to search for patients who had been
prescribed any of the listed drugs at least once and at any
time on record. The records of all patients on this database
were searched to confirm the presence of chronic respira-
tory disease and to identify other chronic conditions. In this
way, a register of individuals with chronic respiratory
disease and a sub-register of those with multimorbidity
were created in each practice. Having completed the
searches in Practices 1 and 2 and identified a prevalence of
chronic respiratory disease of approximately 3%, a power
calculation was performed to estimate the sample size of
charts to be screened in Practice 3 in order to ensure
detection of a similar prevalence with a margin of  1%.
This indicated that 1825 charts needed to be screened. As
Practice 3 had 4030 potential charts, half were randomly
selected by screening every second chart. (See Fig. 2)
Where a patient had documented chronic bronchitis, or
both asthma and chronic obstructive pulmonary disease
(COPD) were documented in the patient record they were
classified as having COPD.
Data collection
The GP researcher extracted data from medical records on
age, sex, socio-economic status, chronic respiratory diag-
nosis, any other chronic conditions recorded, number of
attendances with a doctor or practice nurse in the previous
twelve months and the number of regular medicationsRegistered
population >18yrs
Medical Records
screened
RespiratoryDisease
(% population)
RespiratoryDisease
& Multimorbidity
(% total with
respiratory disease)
* Every second chart was screened in Practice 3, therefore the practice population used was halved.
183
(60.4)
393
(2.9)
649
10560
Practice 1
105
(59.7)
176
(3.5)
269
4971
Practice 2
105
(60.3)
174
(8.6)
413
2015*
Practice 3
393
(60.1)
653
(3.9)
1331
16,946
Total sample
Figure 2 Prevalence of chronic respiratory disease in
participating practices.
Table 2 Socio-economic Status, Gender.
RDA* (%)
n Z 260
RDM* (%)
n Z 393
Total
n Z 653
Low SES* 130 (50) 313 (79) 443 (68)
Female 148 (57) 259 (66) 407 (62)
RDA* Respiratory Disease Alone, RDM* Respiratory
Disease þ Multimorbidity Low SES* Low socio-economic status
(entitled to GMS card as described in Fig. 1).
238 S. O’Kelly et al.recorded in the medical records. This data was collected
between October 2008 and April 2009 and anonymised.
Analysis
Univariate analyses were performed with Pearson c2
statistics. Multivariate analyses were performed using
multiple logistic regression models with goodness of fit
measured using the HosmereLe Cessie test.21 Age, gender
and socio-economic status were included in the multivar-
iate model irrespective of their statistical significance. All
those aged 70 years or more were entitled to free medical
care under the GMS scheme and therefore this could not be
used as an indicator for low socio-economic status in this
age group. Analysis regarding socio-economic status was
therefore restricted to patients under 70 years of age.
Comparisons of utilisation rates and medications between
those with and without multimorbidity were tested for
significance using the Wilcoxon test.22
Results
The drug code and drug searches resulted in a total of 1331
records for screening. Six hundred and fifty three had
chronic respiratory disease and of these, 393 (60%) had
multimorbidity. (See Fig. 2)
As expected, the percentage of patients with multi-
morbidity increased with age. (See Table 1) Among those with
chronic respiratory disease aged 18e29 years, 27% (41/150) of
patients have multimorbidity compared to 90% (86/96) in
those aged over 70. Twenty four percent (159/653) of the total
sample with chronic respiratory disease had one additional
chronic condition, 20% (130/653) had two additional chronic
conditions, and 16% (104/653) had 3 or more additional
conditions. There was a higher prevalence of multimorbidity
among female patients and those with lower socio-economic
status. (See Table 2)
Asthma was the most commonly documented respiratory
diagnosis in this study, making up two-thirds of the total
sample, and 54% of those with respiratory disease and
multimorbidity. The proportion of patients with multi-
morbidity was higher among those with COPD than those
with asthma or other respiratory diagnosis (see Table 3)
Univariate analysis identified significantly higher rates of
multimorbidity in females, patients with low socio-
economic status, and increasing age. In the multivariate
analysis all factors were significantly associated with mul-
timorbdity. (See Fig. 3) A diagnosis of asthma or otherTable 1 Numbers and proportion of patients with and
without multimorbidity by age.
RDA* (%) RDM* (%) Total number
of patients
18e29 years 109 (73) 41 (27) 150
30e45 years 79 (50) 79 (50) 158
46e69 years 62 (25) 187 (75) 249
70 þ years 10 (10) 86 (90) 96
RDA* Respiratory Disease Alone, RDM* Respiratory
Disease þ Multimorbidity.chronic respiratory disease was not significantly associated
with multimorbidity in the multivariate analysis indicating
that the apparent higher rates of multimorbidity in those
with COPD compared with asthma can be attributed to the
older age of those with COPD. The goodness of fit of the
multivariate model was adequate (p Z 0.41).
The median number of regular medications, and median
number of consultations with a GP or practice nurse in the
previous 12 months were significantly higher among those
with respiratory disease and multimorbidity versus those
with respiratory disease alone. Of the total sample, 499
(76.4%) had no consultation with a practice nurse in the
previous year, and 606 (92.8%) had consulted fewer than
three times Table 4.
Details of the co-existing chronic conditions are outlined
in Table 5 with depression, hypertension, cardiovascular
disease and musculoskeletal disorders predominating.
Depression and anxiety were counted as one condition,
even where both were documented in a patient chart as it
is generally accepted that there is clinical overlap in signs,
symptoms and treatment. Where a patient had two distinct
conditions within one category of conditions they were
counted separately, for example peripheral vascular
disease and heart failure or diverticulitis and gastro-oeso-
phageal reflux disease.
Discussion
This study indicated that 60% of patients with chronic respi-
ratory disease identified in a general practice setting have
multimorbidity. As far aswecan ascertain this is thefirst paper
based in primary care which has used chronic respiratory
disease as the index condition and identified the prevalence of
multimorbidity in this population. Strength of this approach is
that it allowsa comparison in patientswith chronic respiratory
disease between those with and without multimorbidity. Our
results are higher than those found by previous studies in
patientswithchronic respiratorydiseasewherea limited list of
co-existing conditionswas used.9e13Our results arealso higherTable 3 Chronic Respiratory Diagnoses.
Diagnosis RDA*
n Z 260 (%)
RDM*
n Z 393
Total
n Z 653 (%)
Asthma 219 (84) 213 (54) 432 (66)
COPD 37 (14) 169 (43) 206 (32)
Other 4 (2) 11 (3) 15 (2)
RDA* Respiratory Disease Alone, RDM* Respiratory
Disease þ Multimorbidity.
Figure 3 Factors associated with multimorbidity (patients aged < 70 years).
Chronic respiratory disease and multimorbidity 239than those found by Van den Akker et al,23 and lower than
those foundbyFortinet al,1 in general practice settings. Fortin
et al recruited consecutive consulting patients for the study,
and therefore the prevalence of multimorbidity will be higher
among this group compared with a population sample of
patients registered in general practice.
Co-existing chronic conditions found in previous studies
were similar to those found in this study, with cardiovascular
disease, diabetes and hypertension among the most preva-
lent.9e13 However, the majority of previous studies recording
co-existing conditions have limited these to a list of pre-
specified diseases such as cardiovascular disease and depres-
sion, with some including both acute and chronic conditions.
A limitation of this study is the lack of a control group
without a respiratory condition for purposes of comparison of
co-existing conditions, attendance rates, and numbers of
medications. However, our findings can be compared with
other primary care studies conducted in the area of multi-
morbidity. In thecurrent study, themediannumberofGPvisits
among those with multimorbidity was 6 and with respiratory
disease alone was 2. This can be comparedwith data from the
Central Statistics Office in Ireland for 2007,which showed that
the average number of consultations with a GP per person per
year was 2.8 nationally.24 Another Irish study in a younger,
deprived population with at least three chronic conditions,2
had a mean number of consultations in the previous twelve
months of 7.2 in those with single morbidity and 11.6 in those
withmultimorbidity. ADutch study compared the consultation
rates among a general practice population and found a mean
annual consultation rate among patients of 3.225 though this
varied from 4.2 to 5.7 in patients with one of five selectedTable 4 Utilisation rates and medications.
Median
(Interquartile range)
RDA* RDM* p Value
GP Visits in 1 year 2 (0e5) 6 (2e10.25) p < 0.0001
Regular Medications 1 (0e2) 4 (2e8) p < 0.0001
RDA* Respiratory Disease Alone, RDM* Respiratory
Disease þ Multimorbidity.chronic diseases and from5.4 to7.4 in patientswithmore than
one of these diseases.
The median number of regular medications in the current
study was 4 among those with multimorbidity and 1 among
those with respiratory disease alone. In comparison, results
from the Irish study of a younger more deprived group of
patients showed that the mean number of medications was
7.3 in patients withmultimorbidity, andwas 2.3 among those
with a single morbidity.2
Factors shown to have significant association with multi-
morbidity in multivariate analysis in the current study were:
low socio-economic status, and increasing age. These find-
ings are similar to the results fromprevious studies in general
practice populations in Canada, the Netherlands, and Scot-
land.1,3,26 Female gender has been found to be significant in
some studies and not in others. In this study gender was not
associated with multimorbidity when controlled for age and
socio-economic status.
A limitation of this study is that it was carried out in three
general practices in one country and consequently thefindings
may not be generalisable. There were differences between
the practices in documentation, coding and prescribing. The
proportion of those documented as having a chronic respira-
tory disease was significantly higher in Practice 3 when
compared with Practices 1 and 2, however the proportion of
patients with chronic respiratory disease and multimorbidity
was consistent across the three practices. It may be that the
prevalence of those documented as having chronic respiratory
disease was higher in Practice 3 due to routine, weekly coding
entries compared with opportunistic disease coding used in
Practices 1 and 2. Under-diagnosis andmisdiagnosis of chronic
respiratory disease in general practice, particularly for COPD,
have been well documented.27e29 Reasons suggested for this
include a nihilistic approach or attitude to COPD by medical
practitioners, and under-presentation by patients of symp-
toms suchaschronic coughor sputumproduction. Studies have
also demonstrated under-use of spirometry in diagnosing
respiratory disease in general practice.30 There is also inter-
national variation in the incentivesprovided toGPs todiagnose
and manage chronic respiratory disease and such incentivisa-
tion generally leads to better diagnosis.31
Table 5 Co-existing chronic conditions in patients with chronic respiratory disease and multimorbidity (n Z 393).
Depression/Anxiety 28% 110
Hypertension 28% 107
Cardiovascular disease
(includes cerebrovascular and
peripheral vascular disease)
28% 96 patients with 1 condition
11 patients with 2 conditions
1 patient with 3 conditions
Musculoskeletal
(includes osteoporosis)
23% 88 patients with 1 condition
1 patient with 2 conditions
Endocrine 20% 76 patients with 1 condition
1 patient with 2 conditions
Gastrointestinal 17% 55 patients with 1 condition
5 patients with 2 conditions
1 patient with 3 conditions
Substance Misuse 14% 54 patients with 1 condition
1 patient with 2 conditions
Hyperlipidaemia, Dermatological, Neurological, Malignancy < 10%
Other psychiatric disorder, Ophthalmological, Metabolic,
Haematological, Renal disorder
< 4%
HIV, Dementia, Benign Prostatic Hyperplasia,
Connective Tissue Disorder, Obesity, Genetic Disorder,
Multisystem Inflammatory Disorder
< 2%
240 S. O’Kelly et al.A second and important limitation is the lack of smoking
data. Smoking status is an important potential confounding
factor in the analysis of multimorbidity among patients with
chronic respiratory disease. However, difficulties obtaining
accurate smoking data in primary care settings have been
highlighted in a report on the Quality and Outcomes
Framework in the UK,32 and smoking data is therefore not
included in some studies on chronic respiratory disease.33
Several other studies have also demonstrated a poor
correlation between GP records and self-report on current
smoking internationally.34e36 None of the participating
practices routinely record and update current smoking
status at every visit. Therefore, we felt that extracting data
from the records would not be accurate and as a result was
not done.
When a patient is attending with one condition and has
regular reviews with a GP are theymore likely to be diagnosed
with additional conditions? This is a difference with specialist
medicine. The need for clarification and consensus on the
definition ofmultimorbidity and constructs for the assessment
of and management of multimorbidity has been highlighted in
recently published work by Starfield et al.37 There are defini-
tional difficulties in distinguishing between co-morbidity and
multimorbidity which will inevitably affect prevalence find-
ings. In co-morbidity there are similar pathogenesis or risk
factors, for example hypertension and cardiovascular disease.
Inmultimorbidity theremaybenocommonpathogenesis as for
example in asthma and arthritis but there is overlap between
the areas of co- and multimorbidity.
There is also the question of whether a co-existing condi-
tion is classified as a disease or as a risk factor. For example,
hyperlipidaemia was included in this study as the diagnosis
involves follow-up consultations, blood tests and may involve
takingmedication and fulfils thedefinitionof a chronicdisease
as specified by the World Health Organisation (WHO) and is
considered a unique condition within the ICPC coding
system.20 Inclusion of hyperlipidaemia did not alter thenumbers of people with multimorbidity in this study but it did
increase the overall number of conditions.
Deprivationhasbeenshowntobeassociatedwith increased
morbidity and mortality, greater numbers of psychological
problems, shorter consultation times, and poorer access to
health services and care.38 Smoking rates are also higher
among those in a lower socio-economic group.39 which further
contributes to increased morbidity and mortality, particularly
for respiratory conditions. Due to their association with
increased morbidity, smoking and deprivation could be
considered as the equivalent of having additional health
conditions in future work on multimorbidity.
Our results showed that multimorbidity is common among
patientswith chronic respiratory disease, and its presence has
an impact on workload and numbers of prescribed medica-
tions. We need to incorporate the concept of multimorbidity
intoourchronicdiseasemanagementprogrammes.40Potential
solutions include the adoption of shared or collaborative care,
though a Cochrane review of studies on shared care between
primary and secondary care did not find evidence for any
significant benefits of shared care over usual care other than
improvedprescribing.41Analternativemodel suchasphysician
guided care has shown promising initial results in a recent US
trial with improvements in patient and physician satisfaction
with chronic care, a reduction in the number of admissions to
hospital anddays spent inhospital anda reduction incaregiver
strain and depression levels.42e44 Respiratory disease is
common in both primary and secondary care and it usually
coexists with other illnesses. Effective management repre-
sents an important clinical challenge for both primary and
secondary care physicians.Ethical approval
The Research Ethics Committee of the Irish College of
General Practitioners approved the study. Data on
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